331 related articles for article (PubMed ID: 25512109)
1. Cancer-associated fibroblasts induce high mobility group box 1 and contribute to resistance to doxorubicin in breast cancer cells.
Amornsupak K; Insawang T; Thuwajit P; O-Charoenrat P; Eccles SA; Thuwajit C
BMC Cancer; 2014 Dec; 14():955. PubMed ID: 25512109
[TBL] [Abstract][Full Text] [Related]
2. Fibroblasts mediate induction of high mobility group box protein 1 in lung epithelial cancer cells by diffusible factors.
Bartling B; Fuchs C; Silber RE; Simm A
Int J Mol Med; 2007 Aug; 20(2):217-24. PubMed ID: 17611640
[TBL] [Abstract][Full Text] [Related]
3. Src/STAT3-dependent heme oxygenase-1 induction mediates chemoresistance of breast cancer cells to doxorubicin by promoting autophagy.
Tan Q; Wang H; Hu Y; Hu M; Li X; Aodengqimuge ; Ma Y; Wei C; Song L
Cancer Sci; 2015 Aug; 106(8):1023-32. PubMed ID: 26041409
[TBL] [Abstract][Full Text] [Related]
4. High ASMA
Amornsupak K; Jamjuntra P; Warnnissorn M; O-Charoenrat P; Sa-Nguanraksa D; Thuwajit P; Eccles SA; Thuwajit C
Clin Breast Cancer; 2017 Oct; 17(6):441-452.e2. PubMed ID: 28533055
[TBL] [Abstract][Full Text] [Related]
5. Substance P Receptor Signaling Mediates Doxorubicin-Induced Cardiomyocyte Apoptosis and Triple-Negative Breast Cancer Chemoresistance.
Robinson P; Kasembeli M; Bharadwaj U; Engineer N; Eckols KT; Tweardy DJ
Biomed Res Int; 2016; 2016():1959270. PubMed ID: 26981525
[TBL] [Abstract][Full Text] [Related]
6. Breast cancer-associated fibroblasts induce epithelial-to-mesenchymal transition in breast cancer cells.
Soon PS; Kim E; Pon CK; Gill AJ; Moore K; Spillane AJ; Benn DE; Baxter RC
Endocr Relat Cancer; 2013 Feb; 20(1):1-12. PubMed ID: 23111755
[TBL] [Abstract][Full Text] [Related]
7. HMGB1-activated fibroblasts promote breast cancer cells metastasis via RAGE/aerobic glycolysis.
Chen Y; Cai L; Guo X; Li Z; Liao X; Zhang X; Huang L; He J
Neoplasma; 2021 Jan; 68(1):71-78. PubMed ID: 33030958
[TBL] [Abstract][Full Text] [Related]
8. Doxorubicin-polyglycerol-nanodiamond conjugate is a cytostatic agent that evades chemoresistance and reverses cancer-induced immunosuppression in triple-negative breast cancer.
Yuan SJ; Xu YH; Wang C; An HC; Xu HZ; Li K; Komatsu N; Zhao L; Chen X
J Nanobiotechnology; 2019 Oct; 17(1):110. PubMed ID: 31623629
[TBL] [Abstract][Full Text] [Related]
9. High mobility group box 1-mediated autophagy promotes neuroblastoma cell chemoresistance.
Wang L; Zhang H; Sun M; Yin Z; Qian J
Oncol Rep; 2015 Dec; 34(6):2969-76. PubMed ID: 26397184
[TBL] [Abstract][Full Text] [Related]
10. Hyaluronic acid-chitosan nanoparticles for co-delivery of MiR-34a and doxorubicin in therapy against triple negative breast cancer.
Deng X; Cao M; Zhang J; Hu K; Yin Z; Zhou Z; Xiao X; Yang Y; Sheng W; Wu Y; Zeng Y
Biomaterials; 2014 May; 35(14):4333-44. PubMed ID: 24565525
[TBL] [Abstract][Full Text] [Related]
11. HMGB1 modulates the balance between senescence and apoptosis in response to genotoxic stress.
Lee JJ; Park IH; Rhee WJ; Kim HS; Shin JS
FASEB J; 2019 Oct; 33(10):10942-10953. PubMed ID: 31284735
[TBL] [Abstract][Full Text] [Related]
12. Influence of doxorubicin on apoptosis and oxidative stress in breast cancer cell lines.
Pilco-Ferreto N; Calaf GM
Int J Oncol; 2016 Aug; 49(2):753-62. PubMed ID: 27278553
[TBL] [Abstract][Full Text] [Related]
13. Insulin like growth factor binding protein-7 reduces growth of human breast cancer cells and xenografted tumors.
Amemiya Y; Yang W; Benatar T; Nofech-Mozes S; Yee A; Kahn H; Holloway C; Seth A
Breast Cancer Res Treat; 2011 Apr; 126(2):373-84. PubMed ID: 20464481
[TBL] [Abstract][Full Text] [Related]
14. Doxorubicin induces cell death in breast cancer cells regardless of Survivin and XIAP expression levels.
Nestal de Moraes G; Vasconcelos FC; Delbue D; Mognol GP; Sternberg C; Viola JP; Maia RC
Eur J Cell Biol; 2013; 92(8-9):247-56. PubMed ID: 24064045
[TBL] [Abstract][Full Text] [Related]
15. The paracrine effects of fibroblasts on Doxorubicin-treated breast cancer cells.
Fourie C; Davis T; Kriel J; Engelbrecht AM
Exp Cell Res; 2019 Aug; 381(2):280-287. PubMed ID: 31121155
[TBL] [Abstract][Full Text] [Related]
16. Peri-foci adipose-derived stem cells promote chemoresistance in breast cancer.
Yeh WL; Tsai CF; Chen DR
Stem Cell Res Ther; 2017 Jul; 8(1):177. PubMed ID: 28750689
[TBL] [Abstract][Full Text] [Related]
17. Synergistic effect of photodynamic treatment and doxorubicin on triple negative breast cancer cells.
Yousefi Sadeghloo A; Khorsandi K; Kianmehr Z
Photochem Photobiol Sci; 2020 Nov; 19(11):1580-1589. PubMed ID: 33030191
[TBL] [Abstract][Full Text] [Related]
18. Resveratrol enhances chemosensitivity of doxorubicin in multidrug-resistant human breast cancer cells via increased cellular influx of doxorubicin.
Kim TH; Shin YJ; Won AJ; Lee BM; Choi WS; Jung JH; Chung HY; Kim HS
Biochim Biophys Acta; 2014 Jan; 1840(1):615-25. PubMed ID: 24161697
[TBL] [Abstract][Full Text] [Related]
19. Enhancement of PD-L1-attenuated CAR-T cell function through breast cancer-associated fibroblasts-derived IL-6 signaling via STAT3/AKT pathways.
Chuangchot N; Jamjuntra P; Yangngam S; Luangwattananun P; Thongchot S; Junking M; Thuwajit P; Yenchitsomanus PT; Thuwajit C
Breast Cancer Res; 2023 Jul; 25(1):86. PubMed ID: 37480115
[TBL] [Abstract][Full Text] [Related]
20. Role of HMGB1 in doxorubicin-induced myocardial apoptosis and its regulation pathway.
Yao Y; Xu X; Zhang G; Zhang Y; Qian W; Rui T
Basic Res Cardiol; 2012 May; 107(3):267. PubMed ID: 22527657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
